Arsenic speciation analysis in human urine for long term epidemiological studies: The Multi-Ethnic Study of Atherosclerosis (MESA)
- PMID: 39179143
- PMCID: PMC11568919
- DOI: 10.1016/j.envres.2024.119833
Arsenic speciation analysis in human urine for long term epidemiological studies: The Multi-Ethnic Study of Atherosclerosis (MESA)
Abstract
Arsenic is a ubiquitous toxic metalloid causing serious health problems. Speciation analysis of arsenic in human urine provides valuable insights for large-scale epidemiological studies and informs on sources of exposure as well as human metabolism. The Multi-Ethnic Study of Atherosclerosis (MESA) is a valuable cohort for assessing chronic low-moderate arsenic exposure and health effects in an ethnically diverse US population. We present a state-of-the-art arsenic speciation analysis methodology and its application to 7677 MESA spot urine samples based on high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry. This method is fast, robust and detects a total of 11 individual As species at method detection limits of 0.02-0.03 μg arsenic/L urine for each individual species. Our analytical approach features excellent mean method accuracy (98%) and precision (5%) for the main arsenic species in urine (arsenobetaine, methylarsonic acid, dimethylarsinic acid, and total inorganic As); intra- (3-6%) and inter-day coefficients of variability (5-6%); column recovery (96 ± 7%); and spike recovery (97 ± 6%). The main arsenic species were detectable in ≥95% of urine samples due to the implementation of an oxidation step. Each individual minor arsenic species was detectable in ≤25% of all urines, although at least one of them was detected in almost half the participants. We identified two minor urinary arsenic species as dimethylarsinoylacetic acid and dimethylarsinoylpropionic acid, potential metabolites of seafood-related arsenicals. We observed differences in individual As species excretion by race/ethnicity, with Asian-American participants featuring 3-4 times higher concentrations compared to other participants. We also found differences by site, body mass index, smoking status, rice intake, and water arsenic levels, potentially indicating different exposures or related to individual bio-metabolism. The proposed approach is suitable for epidemiological studies and the collected data will constitute the base for future research on potential health effects of chronic low-level arsenic exposure.
Keywords: Anion-exchange HPLC-ICPMS/MS; Descriptive statistics; High-throughput urine arsenic speciation analysis; Large-scale epidemiologic studies; Method development; Quality control; Urine arsenic metabolites.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Several authors report financial support was provided by National Heart Lung and Blood Institute. Several authors report financial support was provided by National Center for Advancing Translational Sciences. Several authors report financial support was provided by National Institute of Environmental Health Sciences. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this work.
References
-
- Balarastaghi S, Rezaee R, Hayes AW, Yarmohammadi F, Karimi G, 2022. Mechanisms of arsenic exposure-induced hypertension and atherosclerosis: An updated overview. Biological Trace Element Research. 201, 98–113. - PubMed
-
- Barchowsky A, Roussel RR, Klei LR, James PE, Ganju N, Smith KR, Dudek EJ, 1999. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicology and Applied Pharmacology. 159, 65–75. - PubMed
-
- Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacobs JDR, Kronmal R, Liu K, Clark Nelson J, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP, 2002. Multi-Ethnic Study of Atherosclerosis: Objectives and design. American Journal of Epidemiology. 156, 871–881. - PubMed
-
- Braeuer S, Goessler W, 2019. Arsenic species in mushrooms, with a focus on analytical methods for their determination – A critical review. Analytica Chimica Acta. 1073, 1–21. - PubMed
-
- Chen Y-C, Jenny Su H-J, Guo Y-LL, Hsueh Y-M, Smith TJ, Ryan LM, Lee M-S, Christiani DC, 2003. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes and Control. 14, 303–310. - PubMed
MeSH terms
Substances
Grants and funding
- N01 HC095168/HL/NHLBI NIH HHS/United States
- 75N92020D00001/HL/NHLBI NIH HHS/United States
- R01 ES028758/ES/NIEHS NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- P42 ES033719/ES/NIEHS NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- 75N92020D00002/HL/NHLBI NIH HHS/United States
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- 75N92020D00003/HL/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- 75N92020D00004/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- 75N92020D00007/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- 75N92020D00006/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- P30 ES009089/ES/NIEHS NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials